Evidence map›Paper›PMID 27865045›Full record

ArticleCancer science2017

High KRT8 expression promotes tumor progression and metastasis of gastric cancer.

Jian Fang, Hao Wang, Yun Liu, Fangfang Ding, Ying Ni, Shihe Shao

Open access · goldAbstract read
In one paragraph

Article in Cancer science, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 79 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. From Epithelium to Therapy: Transitional Cells in Lung Fibrosis.American journal of respiratory cell and molecular biology · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jian FangSchool of Medicine, Jiangsu University, Jiangsu, China.
Hao WangSecond People's Hospital of Wuxi, Wuxi, China.
Yun LiuSchool of Medicine, Jiangsu University, Jiangsu, China.
Fangfang DingSchool of Medicine, Jiangsu University, Jiangsu, China.
Ying NiSchool of Medicine, Jiangsu University, Jiangsu, China.
Shihe ShaoSchool of Medicine, Jiangsu University, Jiangsu, China.
Jiangsu University · CNWuxi People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Keratin8 (KRT8) is the major component of the intermediate filament cytoskeleton and predominantly expressed in simple epithelial tissues. Aberrant expression of KRT8 is associated with multiple tumor progression and metastasis. However, the role of KRT8 in gastric cancer (GC) remains unclear. In this study, KRT8 expression was investigated and it was found to be upregulated along with human GC progression and metastasis at both mRNA and protein levels in human gastric cancer tissues. In addition, KRT8 overexpression enhanced the proliferation and migration of human gastric cancer cells, whereas the knock-down of KRT8 by siRNA only inhibited migration of human gastric cancer cells. Integrinβ1-FAK-induced epithelial-mesenchymal-transition (EMT) only existed in the high KRT8 cells. Furthermore, KRT8 overexpression led to increase in p-smad2/3 levels and TGFβ dependent signaling events. KRT8 expression in GC was related to tumor clinical stage and worse survival. Kaplan-Meier analysis proved that KRT8 was associated with overall survival of patients with GC that patients with high KRT8 expression tend to have unfavorable outcome. Moreover, Cox's proportional hazards analysis showed that high KRT8 expression was a prognostic marker of poor outcome. These results provided that KRT8 expression may therefore be a biomarker or potential therapeutic target to identify patients with worse survival.

Indexed as

Disease ProgressionCell AdhesionCell MovementCell ProliferationEpithelial-Mesenchymal TransitionFemaleFocal Adhesion Kinase 1Gastric MucosaHumansIntegrin beta1Kaplan-Meier EstimateKeratin-8MaleMiddle AgedNeoplasm ProteinsProportional Hazards ModelsFocal Adhesion Kinase 1Integrin beta1Keratin-8KRT8 protein, humanNeoplasm ProteinsPTK2 protein, humanRNA, MessengerRNA, NeoplasmRNA, Small InterferingSmad2 ProteinSmad3 ProteinTransforming Growth Factor betaGastric cancerKeratinKeratin8metastasissurvival

Identifiers

PMID27865045
PMCPMC5329158
OpenAlexW2556718701

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.